Publication | Closed Access

Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

Antiparasitic AgentMedicineMalariaParasite ControlDose-selection StudyPharmacotherapyRelapse PreventionPharmacologyDrug Resistance